2000 Year End Review - Industry Report: Healthcare
Charts: [
Total Amount Raised |
Average Amount Raised |
Number of Offerings
]
|
|
| Report Type: | Offer to Most Recent Quote |
| Period: | 01/2000 - 12/2000 |
| Sort Criteria: | Percentage Change |
| Industry: | Healthcare |
| Securities Types: | Common Stock, ADS |
| Underwriting Types: | Firm Committment |
| Region(s): | all regions |
| Foreign Companies: | included |
|
|
|
|
| Number of IPOs: | 77 |
| Largest Company: | Community Health Systems, Inc. |
| Smallest Company: | CareScience, Inc. |
| Best Performer: | First Horizon Pharmaceutical Corp. (+284.7%) |
| Worst Performer: | CareScience, Inc. (-93.5%) |
| Total Amount Raised: | $5977.4 Mil. |
| Average Amount Raised: | $77.6 Mil. |
| Average Percentage Change: | +7.42 % |
|
|
| Company |
Symbol |
Offer
Date |
Offer
Price |
Close Price
on 12/29/00 |
Percent
Change |
Market
Value ($Mil) |
| First Horizon Pharmaceutical Corp. |
FHRX |
5/31 |
$8.00 |
$30.750 |
+284.7% |
$379.4 |
|
| PRAECIS Pharmaceuticals, Inc. |
PRCS |
4/27 |
$10.00 |
$29.250 |
+192.% |
$1169.0 |
|
| Community Health Systems, Inc. |
CYH |
6/9 |
$13.00 |
$35.000 |
+169.3% |
$2603.0 |
|
| InterMune Pharmaceuticals, Inc. |
ITMN |
3/24 |
$20.00 |
$44.625 |
+123.2% |
$901.1 |
|
| Inspire Pharmaceuticals, Inc. |
ISPH |
8/3 |
$12.00 |
$26.063 |
+117.9% |
$639.2 |
|
| Specialty Laboratories, Inc. |
SP |
12/8 |
$16.00 |
$33.125 |
+107.3% |
$668.7 |
|
| EDEN Bioscience Corporation |
EDEN |
9/27 |
$15.00 |
$29.938 |
+99.8% |
$680.6 |
|
| Orchid BioSciences, Inc. |
ORCH |
5/5 |
$8.00 |
$14.000 |
+75.0% |
$448.0 |
|
| Charles River Laboratories Corp. |
CRL |
6/23 |
$16.00 |
$27.375 |
+71.9% |
$884.8 |
|
| Luminex Corp. |
LMNX |
3/30 |
$17.00 |
$26.063 |
+53.1% |
$695.3 |
|
| Dendreon Corp. |
DNDN |
6/16 |
$10.00 |
$15.000 |
+50.0% |
$311.3 |
|
| Adolor Corp. |
ADLR |
11/14 |
$15.00 |
$22.000 |
+46.6% |
$590.7 |
|
| American Medical Systems Holdings, Inc. |
AMMD |
8/11 |
$11.00 |
$15.875 |
+44.1% |
$431.0 |
|
| Rigel Pharmaceuticals, Inc. |
RIGL |
11/29 |
$7.00 |
$10.000 |
+42.5% |
$358.5 |
|
| Paradigm Genetics, Inc. |
PDGM |
5/5 |
$7.00 |
$10.000 |
+42.5% |
$239.1 |
|
| Dyax Corp. |
DYAX |
8/15 |
$15.00 |
$21.203 |
+41.5% |
$383.8 |
|
| Cepheid |
CPHD |
6/21 |
$6.00 |
$8.438 |
+40.3% |
$215.3 |
|
| Genaissance Pharmaceuticals, Inc. |
GNSC |
8/2 |
$13.00 |
$18.000 |
+38.6% |
$388.5 |
|
| Tanox, Inc. |
TNOX |
4/7 |
$28.50 |
$39.188 |
+37.0% |
$1605.7 |
|
| ViroLogic, Inc. |
VLGC |
5/2 |
$7.00 |
$9.125 |
+30.5% |
$179.6 |
|
| Sangamo BioSciences, Inc. |
SGMO |
4/6 |
$15.00 |
$19.500 |
+30.0% |
$406.7 |
|
| Packard Bioscience Co |
PBSC |
4/20 |
$9.00 |
$11.625 |
+29.6% |
$690.5 |
|
| The Medicines Company |
MDCO |
8/8 |
$16.00 |
$20.500 |
+28.2% |
$579.3 |
|
| Pain Therapeutics, Inc. |
PTIE |
7/14 |
$12.00 |
$14.875 |
+23.5% |
$384.2 |
|
| Harvard Bioscience, Inc. |
HBIO |
12/7 |
$8.00 |
$9.875 |
+23.3% |
$244.7 |
|
| POZEN, Inc. |
POZN |
10/11 |
$15.00 |
$18.250 |
+21.6% |
$482.3 |
|
| Esperion Therapeutics, Inc. |
ESPR |
8/10 |
$9.00 |
$10.875 |
+20.3% |
$261.3 |
|
| Array Biopharma, Inc. |
ARRY |
11/17 |
$7.50 |
$8.938 |
+19.7% |
$191.3 |
|
| Rosetta Inpharmatics, Inc. |
RSTA |
8/3 |
$14.00 |
$16.000 |
+14.8% |
$479.1 |
|
| Exelixis, Inc. |
EXEL |
4/11 |
$13.00 |
$14.625 |
+12.% |
$625.4 |
|
| Dynacare Laboratories, Inc. |
DNCR |
11/17 |
$10.00 |
$10.875 |
+8.5% |
$205.3 |
|
| ISTA Pharmaceuticals, Inc. |
ISTA |
8/22 |
$10.50 |
$11.250 |
+7.4% |
$10.4 |
|
| Regeneration Technologies, Inc. |
RTIX |
8/10 |
$14.00 |
$14.250 |
+1.8% |
$303.6 |
|
| Keryx Biopharmaceuticals, Inc. |
KERX |
7/28 |
$10.00 |
$10.125 |
+1.5% |
$190.6 |
|
| Illumina, Inc. |
ILMN |
7/28 |
$16.00 |
$16.063 |
+0.9% |
$506.0 |
|
| DURECT Corp. |
DRRX |
9/28 |
$12.00 |
$12.000 |
+0.0% |
$549.7 |
|
| GenVec, Inc. |
GNVC |
12/12 |
$9.50 |
$9.500 |
+0.0% |
$169.3 |
|
| Genencor International, Inc. |
GCOR |
7/28 |
$18.00 |
$18.000 |
+0.0% |
$1059.6 |
|
| 3-Dimensional Pharmaceuticals, Inc. |
DDDP |
8/4 |
$15.00 |
$14.813 |
-1.4% |
$285.0 |
|
| Genomic Solutions, Inc. |
GNSL |
5/5 |
$8.00 |
$7.625 |
-4.8% |
$173.2 |
|
| Intuitive Surgical, Inc. |
ISRG |
6/13 |
$9.00 |
$8.500 |
-5.5% |
$293.1 |
|
| Telik, Inc. |
TELK |
8/11 |
$7.00 |
$6.625 |
-5.5% |
$139.6 |
|
| Applied Molecular Evolution, Inc. |
AMEV |
7/27 |
$19.00 |
$17.063 |
-10.9% |
$361.8 |
|
| AeroGen, Inc. |
AEGN |
11/10 |
$12.00 |
$10.625 |
-11.5% |
$205.9 |
|
| Arena Pharmaceuticals, Inc. |
ARNA |
7/28 |
$18.00 |
$15.500 |
-13.8% |
$325.4 |
|
| Variagenics, Inc. |
VGNX |
7/21 |
$14.00 |
$11.859 |
-15.9% |
$264.5 |
|
| Ciphergen Biosystems, Inc. |
CIPH |
9/29 |
$16.00 |
$13.250 |
-17.8% |
$339.6 |
|
| Versicor, Inc. |
VERS |
8/3 |
$11.00 |
$8.625 |
-21.9% |
$190.1 |
|
| Lexicon Genetics Inc |
LEXG |
4/7 |
$22.00 |
$16.625 |
-24.3% |
$789.9 |
|
| Kosan Biosciences, Inc. |
KOSN |
10/5 |
$14.00 |
$10.500 |
-25.0% |
$250.4 |
|
| Diversa Corp |
DVSA |
2/14 |
$24.00 |
$17.938 |
-25.5% |
$588.6 |
|
| OraPharma Inc |
OPHM |
3/9 |
$18.00 |
$13.250 |
-26.8% |
$166.9 |
|
| Rita Medical Systems, Inc. |
RITA |
7/27 |
$12.00 |
$8.500 |
-29.6% |
$115.1 |
|
| Transgenomic Inc |
TBIO |
7/18 |
$15.00 |
$10.500 |
-30.0% |
$181.9 |
|
| Deltagen, Inc. |
DGEN |
8/3 |
$15.00 |
$10.438 |
-30.1% |
$300.7 |
|
| Discovery Partners International, Inc. |
DPII |
7/27 |
$18.00 |
$12.125 |
-32.3% |
$271.6 |
|
| MediChem Life Sciences, Inc.(MCR Holdings) |
MCLS |
10/26 |
$7.00 |
$4.625 |
-33.2% |
$117.3 |
|
| Intrabiotics Phamaceuticals, Inc. |
IBPI |
3/28 |
$15.00 |
$9.625 |
-35.3% |
$275.1 |
|
| AtheroGenics, Inc. |
AGIX |
8/9 |
$8.00 |
$5.000 |
-37.% |
$114.0 |
|
| Compugen Ltd. |
CGEN |
8/10 |
$10.00 |
$6.250 |
-37.% |
$157.5 |
|
| Antigenics Inc |
AGEN |
2/4 |
$18.00 |
$11.063 |
-38.3% |
$262.4 |
|
| Vascular Solutions Inc |
VASC |
7/20 |
$12.00 |
$7.375 |
-38.4% |
$88.9 |
|
| deCODE Genetics Inc |
DCGN |
7/18 |
$18.00 |
$10.500 |
-41.6% |
$428.8 |
|
| Aspect Medical Systems Inc |
ASPM |
1/28 |
$15.00 |
$8.625 |
-42.% |
$137.0 |
|
| Argonaut Technologies, Inc. |
AGNT |
7/19 |
$15.00 |
$8.500 |
-43.3% |
$139.4 |
|
| Large Scale Biology Corp. |
LSBC |
8/10 |
$17.00 |
$9.500 |
-44.1% |
$212.4 |
|
| SEQUENOM, Inc. |
SQNM |
2/1 |
$26.00 |
$14.000 |
-46.5% |
$315.3 |
|
| Aclara Biosciences, Inc. |
ACLA |
3/21 |
$21.00 |
$10.875 |
-48.1% |
$339.0 |
|
| Pharsight Corp. |
PHST |
8/9 |
$10.00 |
$4.750 |
-52.% |
$87.5 |
|
| Sonic Innovations Inc |
SNCI |
5/2 |
$14.00 |
$6.688 |
-52.2% |
$126.5 |
|
| Allos Therapeutics, Inc. |
ALTH |
3/28 |
$18.00 |
$8.063 |
-55.0% |
$184.1 |
|
| Crucell N.V. |
CRXL |
10/27 |
$14.89 |
$6.310 |
-57.2% |
$220.2 |
|
| Gemini Genomics, PLC |
GMNI |
7/25 |
$14.00 |
$5.625 |
-59.2% |
$363.9 |
|
| Oratec Interventions, Inc. |
OTEC |
4/5 |
$14.00 |
$5.125 |
-63.9% |
$105.0 |
|
| Curon Medical, Inc. |
CURN |
9/22 |
$11.00 |
$4.016 |
-63.9% |
$74.9 |
|
| Go2Pharmacy.Com (Innovative Health Products) |
GORX |
11/8 |
$7.88 |
$2.750 |
-65.0% |
$19.7 |
|
| CareScience, Inc. |
CARE |
6/29 |
$12.00 |
$0.750 |
-93.5% |
$9.5 |
|
| |
Copyright 1996-2000 IPO Monitor. All rights reserved. Redistribution or publication of this content is
expressly prohibited without the prior written consent of IPO Monitor.
This information is provided AS-IS, without any warranty of any kind.
IPO Monitor makes no claims concerning the accuracy or validity of the
information, and shall not be held liable for any errors, delays,
omissions or use thereof.
Please report problems with this site to:
ipo-admin@ipomonitor.com
|
|
